The University of Chicago Header Logo

Connection

Mitchell C. Posner to Etoposide

Back to Details
This is a "connection" page, showing publications Mitchell C. Posner has written about Etoposide.
Mitchell C. Posner
Connection Strength
0.056
Etoposide
  1. A phase I-II trial of continuous-infusion cisplatin, continuous-infusion 5-fluorouracil, and VP-16 in colorectal carcinoma. Am J Clin Oncol. 1990 Oct; 13(5):455-8.
    View in: PubMed
    Score: 0.023
  2. Resveratrol is an effective inducer of CArG-driven TNF-alpha gene therapy. Cancer Gene Ther. 2008 Mar; 15(3):133-9.
    View in: PubMed
    Score: 0.019
  3. Cisplatin and chronic oral etoposide as salvage therapy for advanced colorectal carcinoma. Am J Clin Oncol. 1995 Aug; 18(4):300-2.
    View in: PubMed
    Score: 0.008
  4. Combined modality therapy for stage IIIA non-small cell carcinoma of the lung. Eur J Cancer. 1993; 29A(4):511-5.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.